Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Friday's After-Market Session

Author: Benzinga Insights | March 15, 2024 05:33pm

Gainers

  • Cue Health (NASDAQ:HLTH) shares increased by 12.1% to $0.22 during Friday's after-market session. The company's market cap stands at $34.8 million. As per the press release, Q4 earnings came out 2 days ago.
  • Aclarion (NASDAQ:ACON) shares increased by 10.39% to $0.44. The market value of their outstanding shares is at $3.1 million.
  • BioSig Technologies (NASDAQ:BSGM) shares increased by 9.39% to $0.58. The market value of their outstanding shares is at $5.4 million.
  • OptiNose (NASDAQ:OPTN) stock increased by 9.09% to $2.04. The company's market cap stands at $229.8 million.
  • SCWorx (NASDAQ:WORX) stock rose 7.55% to $1.85. The market value of their outstanding shares is at $2.2 million.
  • Avenue Therapeutics (NASDAQ:ATXI) shares moved upwards by 7.3% to $0.17. The market value of their outstanding shares is at $6.3 million.

Losers

  • Molecular Templates (NASDAQ:MTEM) shares declined by 12.7% to $2.4 during Friday's after-market session. The company's market cap stands at $12.8 million.
  • Better Therapeutics (NASDAQ:BTTX) shares declined by 7.4% to $0.04. The company's market cap stands at $2.2 million.
  • PaxMedica (NASDAQ:PXMD) stock fell 6.28% to $0.7. The market value of their outstanding shares is at $5.1 million.
  • Aligos Therapeutics (NASDAQ:ALGS) shares declined by 5.26% to $0.9. The market value of their outstanding shares is at $68.1 million. As per the news, the Q4 earnings report came out 3 days ago.
  • Autolus Therapeutics (NASDAQ:AUTL) shares fell 4.99% to $5.53. The market value of their outstanding shares is at $1.2 billion. As per the press release, Q4 earnings came out yesterday.
  • Mersana Therapeutics (NASDAQ:MRSN) stock decreased by 4.97% to $4.79. The market value of their outstanding shares is at $581.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACON ALGS ATXI AUTL BSGM BTTX HLTH MRSN MTEM OPTN PXMD WORX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist